Download Sample, Advanced Vaccines are More Effective to Create Long-Lasting Immune Response Among Cattle and Sheep
Cattle and sheep vaccines are used to prevent the animals from diseases such as Foot and mouth disease (FMD), Bluetongue virus, Lumpy Skin Disease (LMD), Trichomoniasis, Brucellosis, etc. The FMD is a severe, highly transmissible disease in cattle and sheep that has a significant economic impact. These economic impacts not only cause losses in animal productivity but can also drive up the cost of both treatment and vaccination programs. In 2024, a team of Indian scientists made significant progress in understanding the genetic makeup of the virus responsible for lumpy skin disease that led to the deaths of approximately 1 million cattle since May 2022. Advancements in biotechnology and new vaccine technologies make cattle and sheep vaccines more effective whereas, improved vaccine formulation, adjuvant and delivery methods result in improvement of vaccine efficacy.
Cattle and sheep are the major sources of primary as well as secondary food products used by humans in their day-to-day life. As a result, ensuring the health of cattle and sheep has become a top priority, fostering farmers to adopt advanced practices for long-term health and productivity. The competitive conflict is expected to rise, as companies continue to introduce advanced vaccines and expand their distribution network to tap into new streams. Concerns about food security are growing because of variations in food choices brought on by changing lifestyle, as a result need of cattle and sheep vaccines are increasing. These elements bring more opportunities for companies to come up with advancement to market expansion.
Cattle and sheep are the major sources of primary as well as secondary food products used by humans in their day-to-day life. As a result, ensuring the health of cattle and sheep has become a top priority, fostering farmers to adopt advanced practices for long-term health and productivity. The competitive conflict is expected to rise, as companies continue to introduce advanced vaccines and expand their distribution network to tap into new streams. Concerns about food security are growing because of variations in food choices brought on by changing lifestyle, as a result need of cattle and sheep vaccines are increasing. These elements bring more opportunities for companies to come up with advancement to market expansion.
To Exhibit More Efficacious Results Against Transmissive Disease in Cattle and Sheep, Companies are Attributing Extensive R&D Initiatives
According to NCBI (National Centre of Biotechnology Information), the morality rate is 5% in adult animals and the morbidity rate of FMD reaches up to 100%. Hence, this is the cause for serious production losses expressed in low milk production and weight loss due to loss of appetite. The growing demand for animal protein, expansion of livestock production and rising awareness of preventive healthcare bring opportunities for the cattle and sheep vaccines market. The high demand for bovine vaccines is driven by the need to protect the cattle and sheep from life-threatening diseases and to maintain the health of this significant livestock population. The increased adoption of cattle and sheep vaccination programs drives the growth of cattle and sheep vaccine market.
New vaccine manufacturing methods have evolved because of developments in technology and medicine, broad knowledge of immunology, biochemistry, molecular biology among other basic science disciplines, this may help vaccine manufacturers to understand the disease and develop new adjuvants for prevention of diseases. Genetic engineering, proteomics and other technologies have aided in implementing novel vaccine theories, resulting in the discovery of new cattle and sheep vaccines and the improvement of the existing ones. The next generation of vaccines such as subunit vaccines, DNA vaccines, recombinant vaccines and vector vaccines are increasingly gaining scientific and public attention and are being seen as viable replacement to conventional vaccines. Another opportunity to drive cattle and sheep market growth is a collaboration between vaccine manufacturers and research institutes for the development of innovative vaccines.
New vaccine manufacturing methods have evolved because of developments in technology and medicine, broad knowledge of immunology, biochemistry, molecular biology among other basic science disciplines, this may help vaccine manufacturers to understand the disease and develop new adjuvants for prevention of diseases. Genetic engineering, proteomics and other technologies have aided in implementing novel vaccine theories, resulting in the discovery of new cattle and sheep vaccines and the improvement of the existing ones. The next generation of vaccines such as subunit vaccines, DNA vaccines, recombinant vaccines and vector vaccines are increasingly gaining scientific and public attention and are being seen as viable replacement to conventional vaccines. Another opportunity to drive cattle and sheep market growth is a collaboration between vaccine manufacturers and research institutes for the development of innovative vaccines.
Recent Trends in the Cattle and Sheep Vaccine Industry
- The Demand for animal protein is projected to continue to grow.
- Sustainable livestock production practices aim to meet the needs of rising animals for food while minimizing negative environmental impacts.
- Awareness of preventive healthcare grows economies and improve health of cattle and sheep.
- Significant advancement in traditional vaccines such as recombinant, vector and irradiated vaccines.
Explore Our Breakthrough Market Segmentation and Personalize it to Meet Your Business Needs…!
Lack of Adoption of Vaccination by Smallholder Farmer’s may Hamper the Growth of Cattle & Sheep Vaccine Market
Rising of Lumpy skin disease in cattle is the main reason behind slower growth of milk production, animal disease threatens the lives of millions of livestock on a daily basis. Stringent regulations related to vaccine approvals, animal welfare and limited awareness about the benefits of vaccination among cattle and sheep farmers in some regions is a major restrain for market growth. Whereas, the other restrain is a complex approval process and extensive testing requirements which pose a challenge for vaccine manufacturers, leading to delays in product launches. The Animal and Plant Health Inspection Service’s Centre for Veterinary Board (CVB) oversees the regulation of veterinary vaccinations in the United States. Animal health companies are granted product and establishment licences by CVB in order to produce and market veterinary biologics, this may contribute to the growth of cattle and sheep vaccines. Manufacturers can capitalize on the growing demand for advanced vaccines to address evolving threats.
As per NCBI in Nov 2023, in dairy farms with a high percentage of infected cows (more than 20%) the economic loss was estimated at US$ 5500. Such economic losses may hamper the growth of the market. Use of vaccination methods and technological platforms for the cattle and sheep may provide some useful insights. Adoption of vaccination is the only way for healthy cattle and sheep; due to vaccination many diseases can be cured, but the cattle and sheep vaccine market is likely to be hampered by lack of adoption of vaccination by smallholder farmers. For instance, to increase vaccine adoption rates by smallholder farmer education and outreach efforts are needed.
As per NCBI in Nov 2023, in dairy farms with a high percentage of infected cows (more than 20%) the economic loss was estimated at US$ 5500. Such economic losses may hamper the growth of the market. Use of vaccination methods and technological platforms for the cattle and sheep may provide some useful insights. Adoption of vaccination is the only way for healthy cattle and sheep; due to vaccination many diseases can be cured, but the cattle and sheep vaccine market is likely to be hampered by lack of adoption of vaccination by smallholder farmers. For instance, to increase vaccine adoption rates by smallholder farmer education and outreach efforts are needed.
Increasing Transmissive Disease in Cattle and Sheep will Demand Advanced Vaccines in the Market
Continuous R&D investments and initiatives by key players is driving the market growth. For example, In 2024 Boehringer Ingelheim (BI) Pharmaceuticals, Inc had launched its adjuvanted first bluetongue virus serotype-3 vaccine. BI, in partnership with Bioveta, a veterinary manufacturer with a concentration on vaccinations, developed the vaccination and it was intended to be made available in Bluetongue Virus (BTV)-3 affected countries beginning May 2024. LSU (Louisiana State University) researchers had developed a new cost-effective vaccine on Bovine Respiratory Disease (BRD) and related illness. This vaccination would prevent cattle and sheep from clinical signs and mortality. The presence of key players such as Virbac, Pfizer INC., and Bayer AG is expected to drive market growth. Similarly, Government’s growing initiatives to promote vaccination for cattle and livestock in Asia Pacific is expected to make more profits. Government support, regulatory frameworks and public-private partnerships play a critical role in vaccine development, efficacy & distribution to cattle and sheep vaccine producers worldwide. Global core cattle vaccine manufacturers include Merck Animal Health Zoetis, etc. these top 2 companies hold a large share.
Searching for a Country or Region Specific Report?
Unlock industry complexities with reports crafted for selected countries and regions at Reduced Cost
Adoption of Advanced Veterinary Practices can Advance Market Growth Worldwide
On the basis of geography, the cattle and sheep vaccine market is classified in North America, Europe, Asia-Pacific and the rest of the world. North America is forecasted to drive demand for cattle vaccines in the market. Continuous R&D investments by key players and the rapid adoption of efficient vaccines are expected to advance market growth of North America. Due to the development and standardization of diagnostics tests Latin-America is expected to witness remarkably growth during the forecast period. Vaccine development is advancing an accelerated pace in North America which has advanced biotechnology and pharmaceutical industries while focusing on manufacturing useful vaccines; to prevent the cattle from the disease vaccination programmes have become more popular.
According to NCBI (National Centre for Biotechnology Information) the disease is estimated to circulate by 77% of the global livestock population and the incurred cost in Africa is 50% of the total cost of the continent. As per FMD vaccine project in Eastern Africa the highly contagious viral disease affects 77% of cattle, sheep and other cloven-hoofed ruminants as well. There was an FMD outbreak in Indonesia in May 2022. Currently it is present in Asia, the Middle East, Africa, and parts of South America.
According to NCBI (National Centre for Biotechnology Information) the disease is estimated to circulate by 77% of the global livestock population and the incurred cost in Africa is 50% of the total cost of the continent. As per FMD vaccine project in Eastern Africa the highly contagious viral disease affects 77% of cattle, sheep and other cloven-hoofed ruminants as well. There was an FMD outbreak in Indonesia in May 2022. Currently it is present in Asia, the Middle East, Africa, and parts of South America.
The report provides a detailed overview of the cattle and sheep vaccine market insights in regions including North America, Latin America, Europe, Asia-Pacific, Oceania, and the Middle East and Africa. The country-specific assessment for cattle and sheep vaccine market has been offered for all regional market share, along with forecasts, market scope estimates, price point assessment, and impact analysis of prominent countries and regions. Throughout this market research report, Y-o-Y growth and CAGR estimates are also incorporated for every country and region, to provide a detailed view of the cattle and sheep vaccine market. These Y-o-Y projections on regional and country-level markets brighten the political, economic and business environment outlook, which are anticipated to have a substantial impact on the growth of the cattle and sheep vaccine market. Some key country and region included in the cattle and sheep vaccine market report as follows:
| North America | United States, Canada |
| Latin America | Brazil, Mexico, Argentina, Colombia, Chile, Central America Countries, Caribbean Countries, Rest of Latin America |
| Europe | Germany, United Kingdom, France, Italy, Spain, Russia, Poland, Netherlands, Switzerland, Belgium, Sweden, Austria, Norway, Denmark, Czech Republic, Rest of Europe |
| Asia Pacific | China, India, Japan, South Korea, Australia & New Zealand, Indonesia, Singapore, Malaysia, Philippines, Vietnam, Thailand, Bangladesh, Rest of Asia Pacific |
| Middle East and Africa | GCC Countries, South Africa, Nigeria, Egypt, Turkey, Morocco, Ethiopia, Algeria, Israel, Iran, Iraq, Kenya, Rest of MEA |
Cattle and Sheep Vaccine Market Research Report Covers In-depth Analysis on:
- Cattle and sheep vaccine market detailed segments and segment-wise market breakdown
- Cattle and sheep vaccine market dynamics (Recent industry trends, drivers, restraints, growth potential, opportunities in cattle and sheep vaccine industry)
- Current, historical and forthcoming 10 years market valuation in terms of cattle and sheep vaccine market size (US$ Mn), share (%), Y-o-Y growth rate, CAGR (%) analysis
- Cattle and sheep vaccine market demand analysis
- Cattle and sheep vaccine market regional insights with region-wise market breakdown
- Competitive analysis – key companies profiling including their market share, product offerings, and competitive strategies.
- Latest developments and innovations in cattle and sheep vaccine market
- Regulatory landscape by key regions and key countries
- Cattle and sheep vaccine market sales and distribution strategies
- A comprehensive overview of parent market
- A detailed viewpoint on cattle and sheep vaccine market forecast by countries
- Mergers and acquisitions in cattle and sheep vaccine market
- Essential information to enhance market position
- Robust research methodology
- Frequently Asked Questions -
What are the key factors influencing the growth of the cattle and sheep vaccine market?
Factors like increasing demand for disease control in livestock, advancements in vaccine formulations, and rising awareness about animal health are significantly driving market growth.
What types of cattle and sheep vaccines are available in the market?
The market offers various types of vaccines, including inactivated vaccines, live attenuated vaccines, recombinant vaccines, and subunit vaccines, each targeting specific diseases in cattle and sheep.
What are the challenges faced by manufacturers in the cattle and sheep vaccine market?
Manufacturers face challenges like high production costs, regulatory hurdles, and market penetration in developing regions, along with the need for continuous innovation to address emerging diseases in livestock.
